Dr. Alex C. Spyropoulos, MD

Dr. Spyropoulos practices at All Care Medical of NY, P.C. in New Hyde Park, New York.

Dr. Spyropoulos' NPI, 1073622874, was assigned on August 29, 2006. Dr. Spyropoulos graduated from Perelman School of Medicine at the University of Pennsylvania in 1992. Dr. Spyropoulos holds New York license 263234.

Dr. Spyropoulos' primary practice is All Care Medical of NY, P.C., at 2001 Marcus Ave, New Hyde Park, NY 11042 in Nassau County. The practice phone is (516) 442-4077.

Dr. Spyropoulos' primary practice is All Care Medical of NY, P.C. in New Hyde Park, New York. Dr. Spyropoulos is also affiliated with Strong Memorial Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Spyropoulos to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spyropoulos practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Spyropoulos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Spyropoulos is board certified in internal medicine by the American Board of Internal Medicine. Dr. Spyropoulos is licensed in New York.

CMS data shows 77 Medicare services from Dr. Spyropoulos across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $7,090 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Spyropoulos in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spyropoulos' median patient age at 57, with 54% women.

In 2024, Dr. Spyropoulos wrote 95 Medicare Part D claims for 26 patients. 12% of them were for generic drugs. CMS names the drug for 82 of them, across 2 drugs with 11 or more claims each, at $128,190 in total drug cost. In 2023, CMS named 79 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Spyropoulos for performance year 2024, reported through an alternative payment model (APM). Dr. Spyropoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Spyropoulos as offering telehealth.

Dmand AI links 208 papers to Dr. Spyropoulos, published from 2010 to 2025. 2021 was the busiest year, with 23. The most frequent topics are Anticoagulants, Venous Thromboembolism and Hemorrhage. Dr. Spyropoulos has published most often in Thromb Haemost. Dr. Spyropoulos' most frequent co-authors are Alfonso Javier Tafur, MD, Elliot Barnathan, MD and Theodore Erich Spiro, MD.

CMS Open Payments shows 454 general payments to Dr. Spyropoulos from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Janssen Research & Development, LLC paid the most, $405,734. It also lists 10 research payments totaling $21,592 in 2016.

Dr. Spyropoulos graduated from Perelman School of Medicine at the University of Pennsylvania in 1992.